FDA
approval
· 2014-07-30
FDA Approved: DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE — Supplemental Application (Analog Pharma)
Summary
FDA approved a supplemental application for doxylamine succinate and pyridoxine hydrochloride (Analog Pharma), updating the labeling under NDA 021876.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE (DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE)